| 查看: 151 | 回复: 0 | |||
| 当前主题已经存档。 | |||
[交流]
求助：英文翻译（药学）
|
|||
|
In this , a drug is monobiotinylated in parallel with the production of a vector/avidin or a vector/strept avidin (SA) fusion protein. The biotinylated drug is produced in one vial and the vector/avid in fusion protein is produced in another vial, and the 2 vials are mixed before administration. Owing to the extremely high affinity of avid in or SA binding of biotin, there is instantaneous capture of thebiotinylatedneurotherapeutic agent by the vector/avid in or vector/SA fusion protein. Monoclonal antibody/avid in andmab/SA fusion genes and fusion proteins are produced with genetic engineering. Brain drug delivery in rats is possible with the OX26 mousemab to the rat tfr. Brain drug delivery in humans is possible with the genetically engineeredchimeric HIRmab. The activity of the genetically engineeredchimeric HIRmab is identical to that of the originalmurine HIRmab and thechimeric antibody is avidly taken up by the primate brain. The brain uptake of the HIRmab in the rhesus monkey is 2% to 4% of the injected dose which is a level of brain uptake that is 1 to 2 log orders greater than the brain uptake of aneuroactive small molecule such as morphine. |
回复此楼» 猜你喜欢
反应求助
已经有6人回复
-
基于自然哲学类比的风化壳型稀土矿
已经有16人回复
-
看《给阿ma的情书》有感
已经有10人回复
-
2026年WR青拔进展
已经有7人回复
-
职称论文投稿
已经有11人回复
-
中！中！中！
已经有10人回复
-
会评什么时候开始？
已经有4人回复
-
国自然申请五篇代表作大比拼，感觉这个是最重要的
已经有12人回复
-
无聊看看时间戳打发时间
已经有4人回复
-
咨询
已经有3人回复